RE: RE: TF. IMO.17 Jan 2020 13:37
Ray. As for shelving SCIB1. . . why not ? That doesn't mean the branch of science goes away. But Scancell should and Pharma would, go for the best and quickest path to progress. Immunobody might be taken up later maybe. But it's gotta be what helps cancer Patients first and also . . . the miserable matter of making some money too. IMHO
Oh for an IND approval or some CRUK news to lift hopes, on Immunobody !!!!